STAT
@statnews
Reporting from the frontiers of health & medicine.
Sign up for any of our newsletters here:
加入 July 2015
4.7K 正在关注 165.3K 粉丝
Three glaucoma patients have received Life Biosciences' cellular reprogramming drug, with no serious adverse events.
The drug is the first human test of the theory that giving a precise cocktail of proteins could rejuvenate cells back to a younger state.
显示更多
